Find in Library

Lenvatinib for the treatment of radioiodine-refractory differentiated thyroid cancer: treatment optimization for maximum clinical benefit

oleh: L. J. Wirth, C. Durante, D. J. Topliss, E. Winquist, E. Robenshtok, H. Iwasaki, M. Luster, R. Elisei, S. Leboulleux, M. Tahara